My notes from George Church’s plenary talk at ABRF 2012

Image via {a href="http://commons.wikimedia.org/wiki/File:George_Church_at_TED.jpg"}Wikimedia Commons.{/a}

One of the great privileges of working on the marketing side of a life sciences company (compared to the sales side) is the ability to go to a lot of conferences. As a sales representative, it was a hit-or-miss affair, whether I’d be one of the ‘chosen ones’ to go to AGBT, ASHG (now called ICHG), or ABRF.

(For those who are not in genomics, AGBT = Advances in Genome Biology and Technology; ASHG = American Society for Human Genetics; ABRF = Association of Biomolecular Resource Facilities.)

And for a sales rep, it’s a difficult task; you encounter potential customers from many quarters, increasing the sales footprint for the company as a whole, but not so rewarding for your own particular territory. On top of that, you can’t participate in the science per-se, but certainly will have other opportunities to interact with the conference attendees, and glean some of the ‘take-home’ lessons second-hand, if they are so inclined to ask.

Read more

Just what is “Next Generation Technologist” about anyway?

Photo courtesy of {a href="http://www.flickr.com/photos/mknowles/"}mknowles{/a} via Flickr

“The future is already here – it’s just not very evenly distributed.” – William Gibson

This is a blog about next-generation sequencing and it’s intersection with marketing and business in general (primarily), which happens to be my particular area of professional expertise, having focused on next-generation sequencing since late 2006, when Illumina (my then-employer) acquired a startup called Solexa for $417M. I have had product development, product management, marketing (all in the San Diego area with Illumina) and key-account sales roles (in the Mid-Atlantic region of the US serving both the NIH and the entire SouthEast region with Illumina, RainDance Technologies and currently with Life Technologies). I am presently in a marketing role at Life Technologies Corporation (which used to be Applied Biosystems and Invitrogen Corporation), heavily involved with both the Ion Torrent PGM / Proton as well as the SOLiD / 5500 platforms. (More information about me can be found here; if you are interested in anything Ion Torrent and NGS market overall you’ve come to the right place.)

Read more